PL348831A1 - Improvements in or relating to powders - Google Patents
Improvements in or relating to powdersInfo
- Publication number
- PL348831A1 PL348831A1 PL34883199A PL34883199A PL348831A1 PL 348831 A1 PL348831 A1 PL 348831A1 PL 34883199 A PL34883199 A PL 34883199A PL 34883199 A PL34883199 A PL 34883199A PL 348831 A1 PL348831 A1 PL 348831A1
- Authority
- PL
- Poland
- Prior art keywords
- powders
- relating
- improvements
- Prior art date
Links
- 239000000843 powders Substances 0 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9827145A GB9827145D0 (en) | 1998-12-09 | 1998-12-09 | Improvements in or relating to powders |
| PCT/GB1999/004156 WO2000033811A2 (en) | 1998-12-09 | 1999-12-09 | Improvements in or relating to powders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL348831A1 true PL348831A1 (en) | 2002-06-17 |
Family
ID=10843948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL34883199A PL348831A1 (en) | 1998-12-09 | 1999-12-09 | Improvements in or relating to powders |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6989155B1 (en) |
| EP (1) | EP1137399B1 (en) |
| JP (1) | JP4410942B2 (en) |
| CN (1) | CN1334723A (en) |
| AT (1) | AT240093T (en) |
| AU (1) | AU770461B2 (en) |
| BR (1) | BR9916102A (en) |
| CA (1) | CA2353448C (en) |
| CZ (1) | CZ20012043A3 (en) |
| DE (1) | DE69907951T2 (en) |
| DK (1) | DK1137399T3 (en) |
| EA (1) | EA004045B1 (en) |
| ES (1) | ES2198973T3 (en) |
| GB (1) | GB9827145D0 (en) |
| HU (1) | HU0104513A3 (en) |
| MX (1) | MXPA01005584A (en) |
| NO (1) | NO20012825L (en) |
| NZ (1) | NZ511965A (en) |
| PL (1) | PL348831A1 (en) |
| PT (1) | PT1137399E (en) |
| SK (1) | SK284775B6 (en) |
| TR (1) | TR200101591T2 (en) |
| WO (1) | WO2000033811A2 (en) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| US9006175B2 (en) * | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| ES2569949T3 (en) | 1999-06-29 | 2016-05-13 | Mannkind Corporation | pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| JP2001151673A (en) * | 1999-09-06 | 2001-06-05 | Nikken Chem Co Ltd | Production of powdery preparation for inhalation |
| NZ526059A (en) † | 2000-11-30 | 2005-05-27 | Vectura Ltd | Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition |
| EP3269360A1 (en) | 2000-11-30 | 2018-01-17 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| EP1296651B2 (en) * | 2000-06-27 | 2019-07-17 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| CA2413692C (en) * | 2000-06-27 | 2011-10-18 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US8580306B2 (en) | 2000-11-30 | 2013-11-12 | Vectura Limited | Particles for use in a pharmaceutical composition |
| JP2005520843A (en) * | 2002-03-20 | 2005-07-14 | アドバンスト インハレーション リサーチ，インコーポレイテッド | Sustained for respiratory therapeutic formulation |
| JP4681231B2 (en) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | Inhaler |
| US20110123574A1 (en) * | 2002-03-20 | 2011-05-26 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| CA2478327A1 (en) * | 2002-03-20 | 2003-10-02 | Advanced Inhalation Research, Inc. | Hgh (human growth hormone) formulations for pulmonary administration |
| US7754242B2 (en) | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| BRPI0409380A (en) * | 2003-04-14 | 2006-04-18 | Vectura Ltd | Pharmaceutical compositions |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| ES2385934T3 (en) | 2004-08-20 | 2012-08-03 | Mannkind Corporation | Catalysis of the synthesis of dicetopiperazina. |
| DK2314298T3 (en) | 2004-08-23 | 2015-06-15 | Mannkind Corp | Microparticles comprising diketopiperazinsalte for drug delivery |
| GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
| MX2007009656A (en) | 2005-02-10 | 2007-11-07 | Glaxo Group Ltd | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom. |
| US8062670B2 (en) * | 2005-08-05 | 2011-11-22 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
| EP1928423B1 (en) | 2005-09-14 | 2015-12-09 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
| GB0525254D0 (en) * | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| CN104383546A (en) * | 2006-02-22 | 2015-03-04 | 曼金德公司 | Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent |
| DE102006030164A1 (en) * | 2006-06-29 | 2008-01-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative powders |
| DE102006053375A1 (en) | 2006-11-10 | 2008-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for mixing powders |
| US20090048155A1 (en) | 2007-08-15 | 2009-02-19 | Endacea, Inc. | Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection |
| US8785396B2 (en) * | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| JP5603248B2 (en) | 2007-12-21 | 2014-10-08 | エンダセア， インコーポレイテッド | A1 adenosine receptor antagonist |
| SG10201507038VA (en) | 2008-06-13 | 2015-10-29 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
| TWI532497B (en) | 2008-08-11 | 2016-05-11 | 曼凱公司 | Use of ultrarapid acting insulin |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| PL2405963T3 (en) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Apparatus, system and method for measuring resistance of an inhaler |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| MY157166A (en) | 2009-06-12 | 2016-05-13 | Mankind Corp | Diketopiperazine microparticles with defined specific surface areas |
| CA2778698A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
| WO2011094208A2 (en) | 2010-01-26 | 2011-08-04 | Endacea, Inc. | Methods and pharmaceutical compositions for preventing and treating renal impairment |
| BR112012033060A2 (en) | 2010-06-21 | 2018-02-27 | Mannkind Corp | Dry powder drug release system methods |
| WO2012030647A1 (en) * | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| KR20180122475A (en) | 2010-09-29 | 2018-11-12 | 풀매트릭스 오퍼레이팅 컴퍼니, 인크 | Monovalent metal cation dry powders for inhalation |
| CN107854454A (en) * | 2010-11-09 | 2018-03-30 | 曼金德公司 | For treating the composition comprising serotonin receptor agonist and diketopiperazine of antimigraine |
| AU2015249177B2 (en) * | 2010-11-09 | 2017-08-03 | Mannkind Corporation | Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines |
| RU2448717C1 (en) * | 2011-04-20 | 2012-04-27 | Закрытое акционерное общество Научно-производственное предприятие "Тринита" | Method for making anticoagulant-fibrinolytic heparin preparation |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| EP2776053A1 (en) | 2011-10-24 | 2014-09-17 | MannKind Corporation | Methods and compositions for treating pain |
| RU2650035C2 (en) | 2012-07-12 | 2018-04-06 | Маннкайнд Корпорейшн | Dry powder drug delivery systems and methods |
| EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
| WO2014106727A1 (en) | 2013-01-03 | 2014-07-10 | Vectura Limited | Inhaler and formulation |
| BR112015023168A2 (en) | 2013-03-15 | 2017-07-18 | Mannkind Corp | microcrystalline diketopiperazine compositions and methods |
| KR20150135328A (en) | 2013-04-01 | 2015-12-02 | 풀매트릭스 인코퍼레이티드 | Tiotropium dry powders |
| US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US20190177588A1 (en) * | 2017-12-12 | 2019-06-13 | Xotramorphic LLC | Compositions, Methods, and Systems For Producing Flocculent Materials for Special Effects |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| JP3708553B2 (en) * | 1995-04-14 | 2005-10-19 | ネクター セラピューティクス | Powder form pharmaceutical compositions having improved dispersibility |
| GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| ES2343124T3 (en) * | 1999-10-29 | 2010-07-23 | Novartis Ag | Dry powder compositions with improved dispersability. |
-
1998
- 1998-12-09 GB GB9827145A patent/GB9827145D0/en not_active Ceased
-
1999
- 1999-12-09 HU HU0104513A patent/HU0104513A3/en unknown
- 1999-12-09 ES ES99958404T patent/ES2198973T3/en active Active
- 1999-12-09 AU AU15777/00A patent/AU770461B2/en not_active Ceased
- 1999-12-09 PL PL34883199A patent/PL348831A1/en not_active IP Right Cessation
- 1999-12-09 TR TR2001/01591T patent/TR200101591T2/en unknown
- 1999-12-09 US US09/857,392 patent/US6989155B1/en not_active Expired - Fee Related
- 1999-12-09 SK SK777-2001A patent/SK284775B6/en unknown
- 1999-12-09 DK DK99958404T patent/DK1137399T3/en active
- 1999-12-09 AT AT99958404T patent/AT240093T/en not_active IP Right Cessation
- 1999-12-09 JP JP2000586305A patent/JP4410942B2/en not_active Expired - Fee Related
- 1999-12-09 CA CA 2353448 patent/CA2353448C/en not_active Expired - Fee Related
- 1999-12-09 BR BR9916102A patent/BR9916102A/en not_active Application Discontinuation
- 1999-12-09 EP EP19990958404 patent/EP1137399B1/en not_active Expired - Fee Related
- 1999-12-09 NZ NZ51196599A patent/NZ511965A/en not_active IP Right Cessation
- 1999-12-09 CZ CZ20012043A patent/CZ20012043A3/en unknown
- 1999-12-09 EA EA200100636A patent/EA004045B1/en not_active IP Right Cessation
- 1999-12-09 WO PCT/GB1999/004156 patent/WO2000033811A2/en active IP Right Grant
- 1999-12-09 MX MXPA01005584A patent/MXPA01005584A/en unknown
- 1999-12-09 PT PT99958404T patent/PT1137399E/en unknown
- 1999-12-09 DE DE69907951T patent/DE69907951T2/en active Active
- 1999-12-09 CN CN 99816052 patent/CN1334723A/en not_active Application Discontinuation
-
2001
- 2001-06-08 NO NO20012825A patent/NO20012825L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4410942B2 (en) | 2010-02-10 |
| GB9827145D0 (en) | 1999-02-03 |
| US6989155B1 (en) | 2006-01-24 |
| NO20012825L (en) | 2001-06-08 |
| MXPA01005584A (en) | 2003-07-14 |
| JP2002531487A (en) | 2002-09-24 |
| DK1137399T3 (en) | 2003-08-18 |
| PT1137399E (en) | 2003-09-30 |
| AU770461B2 (en) | 2004-02-19 |
| AT240093T (en) | 2003-05-15 |
| SK284775B6 (en) | 2005-11-03 |
| WO2000033811A3 (en) | 2000-10-12 |
| HU0104513A3 (en) | 2003-12-29 |
| EA200100636A1 (en) | 2001-12-24 |
| DE69907951D1 (en) | 2003-06-18 |
| ES2198973T3 (en) | 2004-02-01 |
| EP1137399B1 (en) | 2003-05-14 |
| TR200101591T2 (en) | 2001-11-21 |
| CN1334723A (en) | 2002-02-06 |
| BR9916102A (en) | 2001-09-04 |
| DE69907951T2 (en) | 2004-03-11 |
| EA004045B1 (en) | 2003-12-25 |
| EP1137399A2 (en) | 2001-10-04 |
| WO2000033811A2 (en) | 2000-06-15 |
| HU0104513A2 (en) | 2002-03-28 |
| CA2353448A1 (en) | 2000-06-15 |
| AU1577700A (en) | 2000-06-26 |
| NZ511965A (en) | 2003-09-26 |
| NO20012825D0 (en) | 2001-06-08 |
| CA2353448C (en) | 2010-02-23 |
| CZ20012043A3 (en) | 2001-12-12 |
| SK7772001A3 (en) | 2001-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2355335B (en) | Improvements in or relating to cables | |
| GB2327074B (en) | Improvements in or relating to capsules | |
| GB2350813B (en) | Improvements in or relating to knives | |
| GB2344792B (en) | Improvements in or relating to an air-bag arrangement | |
| GB2327066B (en) | Improvements in or relating to an air-bag | |
| PL344863A1 (en) | Improved in vivo | |
| DE69927412D1 (en) | Phosphitadditive in polyolefinen | |
| GB9726664D0 (en) | Improvements in or relating to ultrasonography | |
| IL125748D0 (en) | Improvements in or relating to contrast agents | |
| HU0000282A3 (en) | Improvements in or relating to contrast agents | |
| GB2355200B (en) | Improvements in or relating to devices | |
| GB9822963D0 (en) | Improvements in or relating to chromatography | |
| GB9827779D0 (en) | Improvements in or relating to appliances | |
| MX9807863A (en) | Improvements in or relating to encapsulation | |
| GB2321004B (en) | Improvements in or relating to enclosures | |
| GB9807977D0 (en) | Improvements in or relating to coating | |
| GB2335545B (en) | Improvements in or relating to enclosures | |
| GB9618635D0 (en) | Improvements in or relating to sensors | |
| HU0102897A3 (en) | Improvements in or relating to packaging | |
| GB2357465B (en) | Improvements in or relating to an air-bag | |
| GB9930728D0 (en) | Improvements in or relating to aircraft | |
| GB9624352D0 (en) | Improvements in or relating to packaging | |
| GB9720108D0 (en) | Improvements in Magnotherapy | |
| GB9818098D0 (en) | Improvements in or relating to bearings | |
| MXPA01005584A (en) | Improvements in or relating to powders. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VOID | Decisions declaring the decisions on the grant of the patents lapsed |